|
| |
 |
|
| ORIGINAL ARTICLE |
|
| Year : 2019 | Volume
: 12
| Issue : 1 | Page : 26-31 |
|
Diagnosis of Toxoplasma gondii infection in pregnant women using automated chemiluminescence and quantitative real time PCR
Ehsan Ahmadpour1, Elmira Zargami2, Mahmoud Mahami-Oskouei3, Adel Spotin3, Abbas Shahbazi3, Hossein Samadi Kafil4, Saba Rajabi2, Paria Alizadeh2, Yagoob Azadi2, Reza Bahaj3, Firouz Shahrivar3, Aleksandra Barac5
1 Infectious and Tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 Students Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Parasitology and Mycology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
4 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
5 Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Serbia
| Date of Submission | 27-Jul-2018 |
| Date of Decision | 14-Dec-2018 |
| Date of Acceptance | 11-Jan-2019 |
| Date of Web Publication | 23-Jan-2019 |
Correspondence Address:
Ehsan Ahmadpour
Department of Parasitology and Mycology, Tabriz University of Medical Sciences, Tabriz
Iran
 Source of Support: None, Conflict of Interest: None  | 6 |
DOI: 10.4103/1995-7645.250341
Objective: To identify serodiagnosis and quantification of Toxoplasma gondii (T. gondii) infection among pregnant women in Salmas, northwest of Iran. Methods: In this cross-sectional study, 276 blood samples were collected from pregnant women referred to the health care centers in Salmas city. The demographic variables were also recorded. Titers of anti-Toxoplasma IgM and IgG antibodies (Ab) were determined using the chemiluminescence immunoassay. Quantitative real-time PCR targeting the T. gondii repeated element gene was also performed on the blood sample. Results: Out of all, 19.92% (55/276) and 2.17% (6/276) patients were seropositive for anti-Toxoplasma IgG and IgM Ab, respectively. Moreover, the presence of T. gondii DNA was observed in 12.31% (34/276) blood samples. A significant relationship was observed between the IgG Ab seropositivity and contact with the cat as a risk factor (P=0.022). Conclusions: The seroprevalence rate of T. gondii infection in pregnant women is relatively low. Consequently, the seronegative pregnant women are at risk, and a considerable rate of positive blood samples for the presence of parasite's DNA should not be ignored. Besides, quantitative real-time PCR could be considered as an accurate method for diagnosis of acute toxoplasmosis especially when the precise results are of the most importance in pregnancy. Limiting contact with cats is also suggested for pregnant women. Keywords: Toxoplasmosis, Toxoplasma gondii, Chemiluminescence immunoassay, Real time PCR, Pregnancy
How to cite this article:
Ahmadpour E, Zargami E, Mahami-Oskouei M, Spotin A, Shahbazi A, Kafil HS, Rajabi S, Alizadeh P, Azadi Y, Bahaj R, Shahrivar F, Barac A. Diagnosis of Toxoplasma gondii infection in pregnant women using automated chemiluminescence and quantitative real time PCR. Asian Pac J Trop Med 2019;12:26-31 |
How to cite this URL:
Ahmadpour E, Zargami E, Mahami-Oskouei M, Spotin A, Shahbazi A, Kafil HS, Rajabi S, Alizadeh P, Azadi Y, Bahaj R, Shahrivar F, Barac A. Diagnosis of Toxoplasma gondii infection in pregnant women using automated chemiluminescence and quantitative real time PCR. Asian Pac J Trop Med [serial online] 2019 [cited 2023 Mar 20];12:26-31. Available from: https://www.apjtm.org/text.asp?2019/12/1/26/250341 |
Foundation:This study was supported by Infectious and Tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran (Grant No. 94/2-5/17).
| 1. Introduction | |  |
Toxoplasma gondii (T. gondii), an obligate intracellular parasite, infects almost all warm blooded animals and is of great importance when cause infections in humans. Toxoplasmosis is highly prevalent infection throughout the world and T. gondii infection is considered as a serious public health problem, with more than 30% of the human populations infected[i,2]. The parasite can infect humans by ingesting undercooked or raw meat containing tissue cysts of the parasite. Furthermore, it can be also transmitted by eating fruits, vegetables and other food sources contaminated by the parasite's oocysts. The soil is also reported to be a potential source of human infections[2],[3].
T. gondii infection is mostly mild and asymptomatic, however, it can cause severe complications to the fetus or immunocompromised humans. T. gondii can transmit the infection during pregnancy to the fetus through placenta and cause congenital toxoplasmosis[2],[4]. Therefore, pregnant women, as well as children with congenital infection, are important risk groups. In seronegative pregnant women, acquired primary T. gondii infection may affect pregnancy and leads to miscarriage or fetal disorders[5],[6]. Acute toxoplasmosis in pregnant women like other healthy non-pregnant individuals is usually asymptomatic. One of the most seen clinical manifestations of acute infection is regional lymphadenopathy[2]. Chronic maternal infection usually does not affect the fetus. Although pregnant women with T. gondii infection generally have no symptoms, the acute infection during pregnancy can lead to potentially tragic outcomes for the fetus and newborn[2],[6].
Fetus or neonate with congenital toxoplasmosis may suffer from visual defects, hearing loss, neurological complications, hematological disorders, seizures, and/or death. Encephalitis, hydrocephalus, hepatitis, microcephalus, lymphadenopathy and death are the other consequences of the congenital toxoplasmosis[7]. Generally the clinical manifestations in infected fetus depend on the maternal immune response, the parasite virulence, and the trimester of pregnancy. Hence, rapid diagnosis and treatment are essential for reducing the severity of the fetal disease[7],[8].
Toxoplasma screening test for pregnant women is part of the TORCH panel (T. gondii, rubella, cytomegalovirus and herpes infections)[9]. The diagnosis of toxoplasmosis is complicated and challenging. Diagnosis of the infection is mostly based on the serological tests, determining concentrations of anti-Toxoplasma IgM and IgG antibodies (Ab) in the patients’ sera. These antibodies can last for months or even years after acute infection, thus these methods cannot differentiate recent infection from past infection. In fact, the use of molecular techniques, that are sensitive and rapid, is crucial for the early diagnosis of congenital toxoplasmosis and active toxoplasmosis in pregnancy[4],[8]. Therefore, the aim of the present study was to identify serodiagnosis, and quantification of T. gondii infection among pregnant women referred to the health care centers in Salmas city, northwest of Iran, in 2016.
| 2. Materials and methods | | |
2.1. Sample collection
In this cross sectional study, 276 blood samples were collected from pregnant women referred to the health care centers in Salmas city, North West of Iran, from the 1st May 2016 to the 1st December 2016 [Figure 1]. The study was approved by the Ethical Committee of Tabriz University of Medical Science (No. 94/2-5/17). All pregnant women signed informed consent for enrollment to the study. Demographic variables were collecting by interview: previous contact with cats; clinical symptoms; educational status; occupation; age; history of consuming raw and undercooked meat, unpasteurized milk or raw vegetable.
The taken blood samples were divided into two groups, one for serum isolation which was left sedentary to clot, and the other in sodium-heparin tubes for buffy coat isolation. Serum samples were isolated after centrifugation of the clotted blood at roughly 2 500 rpm for 10 min. The isolated sera were kept frozen at -20 Ό until being examined. The buffy coat was also isolated by spinning the blood sample containing anti-coagulant at 1 500 rpm for 10 min and stored in 70% ethanol at -20 Ό for DNA extraction.
2.2. Determination of anti-Toxoplasma IgM and IgG antibodies
Anti-Toxoplasma Abs were determined by Ab capture chemiluminescence immunoassay (CLIA) using anti-Toxoplasma IgG and IgM Abs CLIA kits (LIAISON® Toxo IgM and IgG, DiaSorin S.P.A, Italy) applied in LIAISON device (DiaSorin, Germany). The tests were performed by the device automatically according to the manufacturer's setting. Samples with IgM Ab titer <6 IU/mL were regarded as negative, 6 to 8 IU/mL as borderline and 8 IU/mL as positive results. Furthermore, samples with IgG Ab titer <7.2 IU/mL were graded as negative, 7.2 to 8.8 IU/mL as equivocal and 8.8 IU/mL as positive results[8]. All borderline results were twice repeated.
2.3. DNA extraction
The buffy coats were washed twice with phosphate-buffered saline to remove the ethanol, and DNA was extracted using blood genomic DNA extraction mini kit (YTA co., Iran). The extracted DNA samples were kept frozen at -20 Ό for further use.
2.4. Quantitative-PCR
Quantitative PCR reactions (Q-PCR) were performed as previously described[10],[11] in 20 μL of reaction volume with SYBR Green qPCR Master Mix 10 μL (YTA co, Iran) mixed with 1.4 μL template DNA, 7 μL distilled water and 0.8 μL of each primer at a concentration of 1 pmol/μL The following primers were used for amplification of 164-bp fragment of repeated element (RE) gene from T. gondii; F 5’-AGG GAC AGA AGT CGA AGG GG-3’ and R 5’-GCA GCC AAG CCG GAA ACA TC-3’. The amplification protocol was: 10 min at 95 °C°C, 40 cycles at 94 Ό for 30 s (denaturation), 55 °C for 30 s (annealing), and 72 °C °C for 30 s (amplification). Amplification was done by magnetic induction cycler real time PCR machine (Bimolecular system, Australia). Tubes and plastic materials were used as provided by Bimolecular system for magnetic induction cycler machine. All experiments were done in triplicate. Melting curve analysis was performed to verify the correct product size and to ensure the absence of side products or primer dimmers. Also, Toxoplasma DNA extracted from tachyzoites (RH strain) and water were used as the template for positive and negative control, respectively. In order to evaluate the number of parasites in the blood samples, Q-PCR threshold cycle value was used according to standard curve obtained with DNA samples from a range of serial dilutions (1× ×107-1 ×× 101 parasite/mL) of RH strain tachyzoites.
2.5. Data analysis
Data was recorded and analyzed with the SPSS v.18 software (SPSS Inc., Chicago, ILL, USA) using Mann-Whitney and Chi- square tests. The P value <0.05 was considered as significant.
| 3. Results | | |
In total, 276 pregnant women, with the mean age±standard deviation of (33.1±7.5) years were enrolled in the study and screened for Toxoplasma infection. Out of all, 19.92% (55/276) and 2.17% (6/276) pregnant women were positive for anti-Toxoplasma IgG and IgM Abs, respectively. Also, 5/276 (1.81%) pregnant women were positive for both IgM/IgG Abs. Detailed information is summarized in [Table 1]. | Table 1: Results of anti-Toxoplasma IgM and IgG antibodies in 276 studied pregnant women [n (%)].
Click here to view |
Moreover, molecular analysis was performed using Q-PCR on the seropositive pregnant women (either IgG or Ig M positive) (n=56) for confirmation of their Toxoplasma infection status. T. gondii DNA was found in 34/276 (12.3%) blood samples. All of the six women with positive IgM Ab had parasite's DNA in their blood, detected by Q-PCR (P<0.001) [Table 1]. Interestingly, 58.18% (32/55) of patients with positive anti-Toxoplasma IgG Ab had also positive result for T. gondii obtained by Q-PCR (P<0.001) [Table 2]. The IgM positive (6/34) and IgG (32/34) positive individuals harbored an average (2 454.0±918.5) and (1 014.0±255.3) parasite/mL (Mean±SEM) , respectively. Although, IgM-positive individuals showed greater parasite loads; however, there was no statistically significant difference in parasite load between IgM-positive and IgG-positive women (P>0.05). | Table 2: Relationship between ELISA results and RT-PCR for Toxoplasma in 276 pregnant women.
Click here to view |
Using the Kolmogorov-Smirnov test, none of the quantitative variables had abnormal distribution, thus for analysis of these variables, non-parametric Mann-Whitney test was used. The IgG and IgM Ab concentrations and age of the studied women were statistically significantly higher in women with positive results of T. gondii by Q-PCR [Table 3]. | Table 3: Relationship of mean age of studied pregnant women, anti-Toxoplasma IgM and IgG Abs titer and results of RT-PCR test for T. gondii.
Click here to view |
Considering the demographic variables, the frequency of IgG Ab seropositivity was significantly higher among the women being in contact or having a cat as a pet (P=0.022). Furthermore, all the six IgM Ab positive individuals were housewives (P=0.031). No statistically significant relationship was observed considering PCR result, IgG and IgM Ab seropositivity among the other studied demographic variables [Table 4]. | Table 4: Relationship between different socio-demographic variables and results of anti-Toxoplasma IgM Ab, IgG Ab and RT-PCR.
Click here to view |
| 4. Discussion | | |
Toxoplasmosis is the ubiquitous parasitic infection. The importance of acquired toxoplasmosis is mainly in pregnancy, with the risk of severe congenital infection. Chronic maternal infection usually does not affect the fetus, however, the acute toxoplasmosis during pregnancy can lead to serious complications in fetus[5],[6]. The current study investigated the prevalence of T. gondii infection among pregnant women referred to the health care center in Salmas city, northwest of Iran using serological and molecular methods. The results showed that 19.92% and 2.17% of the studied pregnant women were seropositive for anti-Toxoplasma IgG and IgM Abs, respectively. Remarkably, Toxoplasma DNA was detected in 58.18% seropositive pregnant women.
There are many studies on the T. gondii prevalence in the world[6],[12]. The overall seroprevalence rate of T. gondii infection among the Iranian general population is estimated 39.3%[1]. In meta-analysis by Mizani et al., the seroprevalence of T. gondii Abs using the random-effect model in the pregnant women and girls were 43% (95% CI=38%-48%) and 33% (95% CI=23%-43%), respectively[5].
Salmas is located in the northwest Iran. In the literature, the seroprevalence of T. gondii infection was reported as 47.00% and 45.12% in other parts of West Azerbaijan, Iran[13],[14]. In the studies reported from neighboring province, East Azerbaijan, the IgG Ab seropositivity was from 35.1% to 38.66%[15],[16]. In Turkey, a neighboring country of Iran, the T. gondii Absseroprevalence of in women of reproductive age was determined to be 58.3% for IgM Ab and 1% for IgG Ab[17]. The present study shows the low prevalence of T. gondii infection in pregnant women in Salmas compared to the other nearby cities.
The diagnosis of T. gondii infection is based on serological methods for demonstration of specific IgG, IgM, and IgA Abs[8],[18]. There are several serology techniques that could be used. The enzyme-linked immunosorbent assay and indirect immunofluorescence assay are the most common methods in Iran, and recently the CLIA method has been used[15]. In the present study, screening of anti-Toxoplasma IgG and IgM Abs in the pregnant women was done by CLIA. This method is more sensitive, automated, reliable, and convenient technique. However, the seropositivity for anti-Toxoplasma Abs is one of the most challenging situations in pregnant women[18].
Determination of active and acute toxoplasmosis in pregnant women and commencement of a sufficient anti-Toxoplasma treatment, if needed, can prevent the congenital toxoplasmosis and improve the prognosis. Molecular techniques, as alternative tools, have been used for detection of T. gondii DNA in clinical samples[4],[19],[20]. Currently, Q-PCR has been used for detection and quantification of T. gondii DNA in different clinical samples. The variation of the test performance is mostly associated with target genes and primer composition. Most investigators have used the B1 or RE gene for detection[21],[22],[23].
Hence, in the present study Q-PCR molecular technique was performed based on the RE gene of T. gondii for confirmation of active and acute toxoplasmosis. Using Q-PCR, the presence of T. gondii DNA was detected in 12.30% of patients’ blood samples. All individuals with positive anti-Toxoplasma IgM Ab had also parasite's DNA in their peripheral blood. Interestingly, 58.18% of anti-Toxoplasma IgG Ab positive women had also positive results by PCR. Based on these results, Q-PCR technique could be used as a relevant confirmatory test in diagnosis of acute toxoplasmosis. Although laboratory diagnosis of toxoplasmosis is performed using serology, molecular method such as real time PCR is also important in confirmation. As a limitation in this study, the PCR was not performed on seronegative samples due to lack of funding. Hence, in future studies it is better to survey all samples using molecular method. Salehi et al. showed that 33.3% of the pregnant women were seropositive for T. gondii infection in Arak, Iran. They also found parasite's DNA in one cord blood sample after delivery, confirming congenital infection[24]. Our results showed that the parasite's DNA could be found in more than 50% of the T. gondii seropositive pregnant women. Furthermore, the high prevalence and parasite load are indicative as important markers for screening before and during pregnancy. Type II strains are the most prevalent cause of human toxoplasmosis in North America and Europe. Conversely, the majority of strains isolated in Spain were type I [25],[26]. Fuentes et al. determined the types of T. gondii and its association with human toxoplasmosis using genetic analysis of the SAG2 locus[26]. They showed that type I strains were more commonly (75%) found in cases with congenital infection. Type I strains are considered as the most virulent, fast growing and usually causing high level of parasitemia. Therefore T. gondii infection of pregnant women with genotype I can lead to severe fetal abnormalities or abortion.
Further the association between T. gondii infection and potential risk factors were analyzed. Among the pregnant women who participated in the study, there were no significant differences considering age (P=0.084). On the other side, previous contact with cats has been shown as statistically significant risk factor for toxoplasmosis (P=0.022). These results are in agreement with previous meta-analysis data[1],[5]. Surprisingly, all IgM Ab positive pregnant women were housewives (P=0.031). Our results indicate that housewives had higher risks for exposure to this parasite. Although the frequency of IgG Ab seropositivity was higher in housewives than employed women, there was no statistically significant difference between occupational groups.
In conclusion, the results of the present study show that, pregnant women in Salmas city have a low anti-Toxoplasma Abs seroprevalence compared to most parts of Iran. The seronegative pregnant women are considered susceptible to T. gondii infection and women of childbearing age are at the higher risk. Therefore, pregnant women require regular checks for seroconversion. On the other hand, considerable rate of positive blood samples for the presence of parasite's DNA should be considered. Based on the present findings, Q-PCR is an accurate method and it could be used for fast and precise diagnosis/confirmation of acute and active toxoplasmosis. Furthermore, defining of the population structure at risk for T. gondii infections could lead to more effective prevention strategies. Finally, limitation of the contacts with the cats is also highly suggestive to pregnant women.
Conflict of interest statement
Authors declare there is no any conflict of interest. The sponsor or funding organization had no role in the design or conduct of this research.
Foundation project
This study was prepared from Elmira Zarghami's MSc thesis and supported by Infectious and Tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran (Grant No. 94/2-5/17).
| References | | |
| 1. | Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop 2014; 137: 185-194.  |
| 2. | Hill DE, Chirukandoth S, Dubey J. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 2005; 6: 41-61. |
| 3. | Sarvi S, Daryani A, Rahimi MT, Aarabi M, Shokri A, Ahmadpour E, et al. Cattle toxoplasmosis in Iran: a systematic review and meta-analysis. Asian Pac J Trop Med 2015; 8: 120-126. |
| 4. | Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis 2012; 44: 805-814. |
| 5. | Mizani A, Alipour A, Sharif M, Sarvi S, Amouei A, Shokri A, et al. Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis. Trop Med Health 2017; 45: 7. |
| 6. | Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: A systematic review. Bull World Health Organ 2013; 91: 501-508. |
| 7. | Paquet C, Yudin MH, Allen VM, Bouchard C, Boucher M, Caddy S, et al. Toxoplasmosis in pregnancy: Prevention, screening, and treatment. J Obstet Gynaecol Can 2013; 35: 78-79. |
| 8. | Pomares C, Montoya JG. Laboratory diagnosis of congenital toxoplasmosis. J Clin Microbiol 2016; 54: 2448-2454. |
| 9. | Stegmann B, Carey J. TORCH infections. toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, cytomegalovirus (CMV), and herpes infections. Curr Womens Health Rep 2002; 2: 253-258. |
| 10. | Deilami KN, Daryani A, Ahmadpour E, Sharif M, Dadimoghaddam Y, Sarvi S, et al. Excretory-secretory antigens: asuitable candidate for immunization against ocular toxoplasmosis in a murine model. Comp Immunol Microbiol Infect Dis 2014; 37: 369-374. |
| 11. | Montazeri M, Ebrahimzadeh MA, Ahmadpour E, Sharif M, Sarvi S, Daryani A. Evaluation of propranolol effect on experimental acute and chronic toxoplasmosis using quantitative PCR. Antimicrob Agents Chemother 2016; 60: 7128-7133. |
| 12. | Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 2009; 39: 1385-1394. |
| 13. | Sadaghian M, Amani S, Jafari R. Prevalence of toxoplasmosis and related risk factors among humans referred to main laboratories of Urmia city, North West of Iran, 2013. J Parasit Dis 2016; 40: 520-523. |
| 14. | Rasouli S, Sadaghian M, Jafari R. Prevalence of human toxoplasmosis and related risk factors using Electrochemiluminescence (ECLIA) method in West Azarbaijan Province, Iran, 2010. Int J Biosci 2014; 4: 124-130. |
| 15. | Bahhaj R, Ahmadpour E, Mahami-Oskouei M, Fallah E, Shamsasenjan K, Safaiyan A. Toxoplasma gondiiinfection and related risk factors among blood donors in Northwest Iran. Arch Clin Infect Dis 2017; 2(2): e62005. |
| 16. | Jafari R, Sadaghian M, Safari M. Seroprevalence of Toxoplasma gondii infection and related risk factors in Tabriz city, Iran, 2008. J Res Health Sci 2012; 12: 119-121. |
| 17. | Doni NY, Simsek Z, Gurses G, Zeyrek FY, Demir C. Prevalence and associated risk factors of Toxoplasma gondii in female farmworkers of southeastern Turkey. J Infect Dev Ctries 2015; 9: 87-93. |
| 18. | Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, et al. Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis 2016; 84: 22-33. |
| 19. | Bastien P. Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg 2002; 96: S205-S215. |
| 20. | Switaj K, Master A, Skrzypczak M, Zaborowski P. Recent trends in molecular diagnostics for Toxoplasma gondii infections. Clin Microbiol Infect 2005; 11: 170-176. |
| 21. | Cassaing S, Bessieres M, Berry A, Berrebi A, Fabre R, Magnaval J. Comparison between two amplification sets for molecular diagnosis of toxoplasmosis by real-time PCR. J Clin Microbiol 2006; 44: 720-724. |
| 22. | Calderaro A, Piccolo G, Gorrini C. Comparison between two real-time PCR assays and a nested-PCR for the detection of Toxoplasma gondii. Acta Biomed 2006; 77: 75-80. |
| 23. | Dadimoghaddam Y, Daryani A, Sharif M, Ahmadpour E, Hossienikhah Z. Tissue tropism and parasite burden of Toxoplasma gondii RH strain in experimentally infected mice. Asian Pac J Trop Med 2014; 7: 521-524. |
| 24. | Shieh M, Didehdar M, Hajihossein R, Ahmadi F, Eslamirad Z. Toxoplasmosis: Seroprevalence in pregnant women, and serological and molecular screening in neonatal umbilical cord blood. Acta Trop 2017; 174: 38-44. |
| 25. | Rico-Torres CP, Vargas-Villavicencio JA, Correa D. Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review. Eur J Clin Microbiol Infect Dis 2016; 35: 1079-1088. |
| 26. | Fuentes I, Rubio JM, Ramírez C, Alvar J. Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: Direct analysis from clinical samples. J Clin Microbiol 2001; 39: 1566-1570. |
[Figure 1]
[Table 1], [Table 2], [Table 3], [Table 4]
| This article has been cited by | | 1 |
Leaf hydroalcoholic extract and oleoresin from Copaifera multijuga control Toxoplasma gondii infection in human trophoblast cells and placental explants from third-trimester pregnancy |
|
| Aryani Felixa Fajardo Martínez, Samuel Cota Teixeira, Guilherme de Souza, Alessandra Monteiro Rosini, Joed Pires de Lima Júnior, Gabriel Nogueira Melo, Kelvin Orlando Espinoza Blandón, Angelica Oliveira Gomes, Sergio Ricardo Ambrósio, Rodrigo Cassio Sola Veneziani, Jairo Kenupp Bastos, Carlos Henrique Gomes Martins, Eloisa Amália Vieira Ferro, Bellisa Freitas Barbosa | | Frontiers in Cellular and Infection Microbiology. 2023; 13 | | [Pubmed] | [DOI] | | | 2 |
A novel enhanced dot blot immunoassay using colorimetric biosensor for detection of Toxoplasma gondii infection |
|
| Hanie Safarpour,Mohammad Pourhassan-Moghaddam,Adel Spotin,Hassan Majdi,Aleksandra Barac,Mehdi Yousefi,Ehsan Ahmadpour | | Comparative Immunology, Microbiology and Infectious Diseases. 2021; 79: 101708 | | [Pubmed] | [DOI] | | | 3 |
Frequency and parasite load of Toxoplasma gondii in hemodialysis patients based on RE gene by real-time PCR |
|
| Hadi Mirahmadi,Batol Nozari,Vahid Raissi,Ebrahim Alijani,Soudabeh Etemadi | | Gene Reports. 2021; 23: 101145 | | [Pubmed] | [DOI] | | | 4 |
Toxoplasma gondii infection in patients with malignant and benign bone tumours |
|
| M. Hajizadeh, R. Falak, M. Tavakoli, R. Hosseinzadeh, M. Alipour, E. Ahmadpour, R. Rafiei-Sefiddashti | | Russian Journal of Infection and Immunity. 2021; | | [Pubmed] | [DOI] | | | 5 |
Targeting Strategies in Therapeutic Applications of Toxoplasmosis: Recent Advances in Liposomal Vaccine Delivery Systems |
|
| Yaghob Azadi,Ehsan Ahmadpour,Amirhossein Ahmadi | | Current Drug Targets. 2020; 21(6): 541 | | [Pubmed] | [DOI] | | | 6 |
Sero-molecular evaluation of Toxoplasma gondii infection among HIV-positive patients |
|
| Ehsan Ahmadpour,Reza Pishkarie-Asl,Adel Spotin,Hossein Samadi Kafil,Hasan Didarlu,Yaghob Azadi,Aleksandra Barac | | Transactions of The Royal Society of Tropical Medicine and Hygiene. 2019; | | [Pubmed] | [DOI] | |
|
 |
|
|
|
Search Pubmed for